Annual SGA
$63.58 M
-$6.77 M-9.62%
December 31, 2023
Summary
- As of February 7, 2025, ATAI annual SGA is $63.58 million, with the most recent change of -$6.77 million (-9.62%) on December 31, 2023.
- During the last 3 years, ATAI annual SGA has fallen by -$17.15 million (-21.25%).
- ATAI annual SGA is now -31.44% below its all-time high of $92.75 million, reached on December 31, 2021.
Performance
ATAI SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$10.27 M
-$3.13 M-23.38%
September 30, 2024
Summary
- As of February 7, 2025, ATAI quarterly SGA is $10.27 million, with the most recent change of -$3.13 million (-23.38%) on September 30, 2024.
- Over the past year, ATAI quarterly SGA has dropped by -$3.37 million (-24.69%).
- ATAI quarterly SGA is now -85.74% below its all-time high of $71.98 million, reached on December 31, 2020.
Performance
ATAI Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.42 B
-$128.60 M-5.60%
September 30, 2024
Summary
- As of February 7, 2025, ATAI TTM SGA is -$2.42 billion, with the most recent change of -$128.60 million (-5.60%) on September 30, 2024.
- Over the past year, ATAI TTM SGA has dropped by -$2.48 billion (-4149.03%).
- ATAI TTM SGA is now -7961.07% below its all-time high of $30.85 million.
Performance
ATAI TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ATAI Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -9.6% | -24.7% | -4149.0% |
3 y3 years | -21.3% | -42.9% | -2490.1% |
5 y5 years | +756.4% | -42.9% | -2490.1% |
ATAI Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -31.4% | at low | -60.3% | at low | -130.1% | at low |
5 y | 5-year | -31.4% | +1149.2% | -85.7% | +553.8% | -3183.6% | at low |
alltime | all time | -31.4% | +1551.1% | -85.7% | +253.1% | -7961.1% | at low |
Atai Life Sciences NV Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $10.27 M(-23.4%) | $55.64 M(-5.7%) |
Jun 2024 | - | $13.40 M(+6.7%) | $59.01 M(-5.1%) |
Mar 2024 | - | $12.55 M(-35.4%) | $62.17 M(-2.2%) |
Dec 2023 | $63.58 M(-9.6%) | $19.42 M(+42.5%) | $63.58 M(+6.2%) |
Sep 2023 | - | $13.63 M(-17.7%) | $59.89 M(-8.8%) |
Jun 2023 | - | $16.56 M(+18.5%) | $65.67 M(-1.0%) |
Mar 2023 | - | $13.97 M(-11.2%) | $66.34 M(-5.7%) |
Dec 2022 | $70.35 M(-24.1%) | $15.73 M(-19.0%) | $70.35 M(-12.6%) |
Sep 2022 | - | $19.42 M(+12.8%) | $80.50 M(-1.0%) |
Jun 2022 | - | $17.22 M(-4.2%) | $81.34 M(-19.8%) |
Mar 2022 | - | $17.98 M(-30.5%) | $101.45 M(+9.4%) |
Dec 2021 | $92.75 M(+14.9%) | $25.88 M(+27.7%) | $92.75 M(-33.2%) |
Sep 2021 | - | $20.26 M(-45.7%) | $138.85 M(+13.0%) |
Jun 2021 | - | $37.33 M(+302.6%) | $122.92 M(+39.0%) |
Mar 2021 | - | $9.27 M(-87.1%) | $88.44 M(+9.5%) |
Dec 2020 | $80.73 M(+1486.1%) | $71.98 M(+1563.2%) | $80.73 M(+418.1%) |
Sep 2020 | - | $4.33 M(+51.8%) | $15.58 M(-6.4%) |
Jun 2020 | - | $2.85 M(+81.6%) | $16.65 M(+2.6%) |
Mar 2020 | - | $1.57 M(-77.0%) | $16.22 M(-2.6%) |
Dec 2019 | $5.09 M(-31.4%) | - | - |
Dec 2019 | - | $6.83 M(+26.7%) | $16.65 M(+39.5%) |
Sep 2019 | - | $5.39 M(+122.5%) | $11.94 M(+56.1%) |
Jun 2019 | - | $2.42 M(+20.8%) | $7.65 M(+0.1%) |
Mar 2019 | - | $2.01 M(-5.4%) | $7.65 M(+2.4%) |
Dec 2018 | $7.42 M(+12.1%) | $2.12 M(+92.5%) | $7.47 M(+39.6%) |
Sep 2018 | - | $1.10 M(-54.5%) | $5.35 M(-43.1%) |
Jun 2018 | - | $2.42 M(+32.4%) | $9.41 M(-27.5%) |
Mar 2018 | - | $1.83 M(-64.6%) | $12.97 M(+44.9%) |
Dec 2017 | $6.62 M(+8.1%) | - | - |
Sep 2017 | - | $5.16 M(-13.8%) | $8.96 M(+10.6%) |
Jun 2017 | - | $5.99 M(-189.3%) | $8.10 M(+27.5%) |
Mar 2017 | $6.12 M(-67.8%) | -$6.71 M(-248.5%) | $6.35 M(-62.9%) |
Dec 2016 | - | $4.52 M(+5.0%) | $17.13 M(-0.6%) |
Sep 2016 | - | $4.30 M(+1.4%) | $17.24 M(-0.4%) |
Jun 2016 | - | $4.24 M(+4.1%) | $17.31 M(-9.2%) |
Mar 2016 | $19.02 M | $4.07 M(-12.0%) | $19.07 M(-2.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2015 | - | $4.63 M(+5.9%) | $19.57 M(+4.4%) |
Sep 2015 | - | $4.37 M(-27.1%) | $18.74 M(-1.0%) |
Jun 2015 | - | $6.00 M(+31.0%) | $18.92 M(+6.7%) |
Mar 2015 | $17.74 M(-8.7%) | $4.58 M(+20.4%) | $17.73 M(-3.5%) |
Dec 2014 | - | $3.80 M(-16.4%) | $18.38 M(-8.3%) |
Sep 2014 | - | $4.55 M(-5.3%) | $20.05 M(+5.8%) |
Jun 2014 | - | $4.81 M(-8.0%) | $18.94 M(-2.5%) |
Mar 2014 | $19.43 M(+2.1%) | $5.22 M(-4.5%) | $19.43 M(+9.1%) |
Dec 2013 | - | $5.47 M(+58.9%) | $17.82 M(-0.1%) |
Sep 2013 | - | $3.44 M(-35.0%) | $17.84 M(-5.2%) |
Jun 2013 | - | $5.30 M(+46.9%) | $18.83 M(-1.0%) |
Mar 2013 | $19.03 M(+12.8%) | $3.61 M(-34.3%) | $19.02 M(+0.0%) |
Dec 2012 | - | $5.49 M(+24.0%) | $19.02 M(+7.0%) |
Sep 2012 | - | $4.43 M(-19.4%) | $17.78 M(-3.2%) |
Jun 2012 | - | $5.50 M(+52.5%) | $18.37 M(+8.9%) |
Mar 2012 | $16.87 M(+4.3%) | $3.60 M(-15.4%) | $16.86 M(-0.1%) |
Dec 2011 | - | $4.26 M(-15.1%) | $16.88 M(-3.1%) |
Sep 2011 | - | $5.02 M(+25.8%) | $17.42 M(+6.8%) |
Jun 2011 | - | $3.99 M(+10.2%) | $16.31 M(+0.7%) |
Mar 2011 | $16.18 M(+15.3%) | $3.62 M(-24.6%) | $16.20 M(+2.4%) |
Dec 2010 | - | $4.80 M(+22.9%) | $15.82 M(+10.0%) |
Sep 2010 | - | $3.90 M(+0.6%) | $14.38 M(-0.8%) |
Jun 2010 | - | $3.88 M(+19.7%) | $14.50 M(+3.3%) |
Mar 2010 | $14.04 M(+32.8%) | $3.24 M(-3.5%) | $14.04 M(+12.2%) |
Dec 2009 | - | $3.36 M(-16.4%) | $12.51 M(+1.3%) |
Sep 2009 | - | $4.02 M(+17.5%) | $12.34 M(+8.5%) |
Jun 2009 | - | $3.42 M(+99.8%) | $11.37 M(+7.6%) |
Mar 2009 | $10.57 M(+14.3%) | $1.71 M(-46.4%) | $10.57 M(-9.6%) |
Dec 2008 | - | $3.19 M(+4.8%) | $11.69 M(+4.6%) |
Sep 2008 | - | $3.05 M(+16.4%) | $11.18 M(+10.9%) |
Jun 2008 | - | $2.62 M(-7.5%) | $10.08 M(+35.1%) |
Mar 2008 | $9.25 M(+34.9%) | $2.83 M(+5.5%) | $7.46 M(+61.1%) |
Dec 2007 | - | $2.68 M(+37.4%) | $4.63 M(+137.4%) |
Sep 2007 | - | $1.95 M | $1.95 M |
Mar 2007 | $6.85 M(+78.0%) | - | - |
Mar 2006 | $3.85 M | - | - |
FAQ
- What is Atai Life Sciences NV annual SGA?
- What is the all time high annual SGA for Atai Life Sciences NV?
- What is Atai Life Sciences NV annual SGA year-on-year change?
- What is Atai Life Sciences NV quarterly SGA?
- What is the all time high quarterly SGA for Atai Life Sciences NV?
- What is Atai Life Sciences NV quarterly SGA year-on-year change?
- What is Atai Life Sciences NV TTM SGA?
- What is the all time high TTM SGA for Atai Life Sciences NV?
- What is Atai Life Sciences NV TTM SGA year-on-year change?
What is Atai Life Sciences NV annual SGA?
The current annual SGA of ATAI is $63.58 M
What is the all time high annual SGA for Atai Life Sciences NV?
Atai Life Sciences NV all-time high annual SGA is $92.75 M
What is Atai Life Sciences NV annual SGA year-on-year change?
Over the past year, ATAI annual SGA has changed by -$6.77 M (-9.62%)
What is Atai Life Sciences NV quarterly SGA?
The current quarterly SGA of ATAI is $10.27 M
What is the all time high quarterly SGA for Atai Life Sciences NV?
Atai Life Sciences NV all-time high quarterly SGA is $71.98 M
What is Atai Life Sciences NV quarterly SGA year-on-year change?
Over the past year, ATAI quarterly SGA has changed by -$3.37 M (-24.69%)
What is Atai Life Sciences NV TTM SGA?
The current TTM SGA of ATAI is -$2.42 B
What is the all time high TTM SGA for Atai Life Sciences NV?
Atai Life Sciences NV all-time high TTM SGA is $30.85 M
What is Atai Life Sciences NV TTM SGA year-on-year change?
Over the past year, ATAI TTM SGA has changed by -$2.48 B (-4149.03%)